All In MedTech

Device Trial Radar · NCT05843721

Post-marketing Clinical Follow-up for Long-term Use of Intranasal Kinetic Oscillation in Subjects With Chronic Migraine

An Open Post-marketing Clinical Follow-up Investigation to Follow Long-term Performance and Safety of Intranasal Kinetic Oscillation in Subjects With Chronic Migraine

Last checked: Nov 20, 2026Latest source record: Sep 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

98

Actual

Start

Nov 8, 2023

Primary completion

Aug 31, 2025

Study completion Aug 31, 2025

Sponsor

Lead sponsor
Chordate MedicalNot on our public-company list
Sponsor type
Industry
First posted
May 6, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Prevention
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

An non controlled, long term, multi center investigation

Conditions

  • Chronic Migraine

Interventions

  • KOS (Intranasal kinetic oscillation stimulation)Device

    Treatment is 10 minutes in each nasal cavity. Totally 2 x 10 minutes per treatment.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To evaluate the efficacy of intranasal kinetic oscillation stimulation using the Chordate System S220 on monthly headache days with moderate to severe intensity after approx 6 weeks of treatment.Time frame: Baseline to 6 weeks

Locations

12 sites in 4 countries. Site status is shown where the registry gives one.

  • Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden UniversitätsSchmerzCentrum

    Dresden, Germany

11 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.